Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cells

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1585-1592

  Kaur, Manjinder ^a   Deep, Gagan ^a,b   Jain, Anil K ^a   Raina, Komal ^a   Agarwal, Chapla ^a,b   Wempe, Michael F ^a,b   Agarwal, Rajesh ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANNEXIN; BIOLOGICAL MARKER; CASPASE 3; CYTOCHROME C; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN P21; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOSENSOR; CANCER GROWTH; CARCINOMA CELL; CELL DEATH; CELL ENERGY; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FRUIT JUICE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOMORDICA CHARANTIA; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOSOL; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MOMORDICA; PANCREATIC NEOPLASMS; PLANT EXTRACTS; PROTEIN KINASES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84880293110     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt081     Document Type: Article

References (58)

1. Siegel, R. et al. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA. Cancer J. Clin., 61, 212-236.
2. Gaviraghi, M. et al. (2011) Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. Biosci. Rep., 31, 45-55.
3. Krawinkel, M.B. et al. (2006) Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia. Nutr. Rev., 64331-337.
4. Nerurkar, P. et al. (2010) Bitter melon: antagonist to cancer. Pharm. Res., 27, 1049-1053.
5. Leung, L. et al. (2009) Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. Br. J. Nutr., 102,1703-1708.
6. Fuangchan, A. et al. (2011) Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J. Ethnopharmacol., 134, 422-428.
7. Takemoto, D.J. et al. (1982) Purification and characterization of a cytostatic factor from the bitter melon Momordica charantia. Prep. Biochem., 12,355-375.
8. Grossmann, M.E. et al. (2009) Eleostearic acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism. Cancer Prev. Res.(Phila)., 2, 879-886.
9. Kohno, H. et al. (2004) Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPARgamma expression and alteration of lipid composition. Int. J. Cancer, 110, 896-901.
10. Ray, R.B. et al. (2010) Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res., 70, 1925-1931.
11. Ru, P. et al. (2011) Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model. Cancer Prev. Res. (Phila)., 4, 2122-2130.
12. Li, D. (2012) Diabetes and pancreatic cancer. Mol. Carcinog., 51, 64-74.
13. Sadeghi, N. et al. (2012) Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin. Cancer Res., 18, 2905-2912.
14. Vander Heiden, M.G. (2011) Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov., 10, 671-684.
15. Vander Heiden, M.G. et al. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324, 1029-1033.
16. Hardie, D.G. (2011) AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev., 25, 1895-1908.
17. Hardie, D.G. (2011) AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem. Soc. Trans., 39, 1-13.
18. Hardie, D.G. (2007) AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol., 47, 185-210.
19. Xiang, X. et al. (2004) AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms. Biochem. Biophys. Res. Commun., 321, 161-167.
20. Shackelford, D.B. et al. (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer, 9, 563-575.
21. Rattan, R. et al. (2005) 5-Aminoimidazole-4-carboxamide-1-beta-Dribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J. Biol. Chem., 280, 39582-39593.
22. Lee, S.K. et al. (2009) N(1)-guanyl-1,7,-diamineoheptane, an inhibitor of deoxyhypusine synthase, suppresses differentiation and induces apoptosis via mitochondrial and AMPK pathways in immortalized and malignant human oral keratinocytes. J. Oral Pathol. Med., 38, 792-800.
23. Chen, M.B. et al. (2011) Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell. J. Cell. Physiol., 226, 1915-1925.
24. Huang, C.H. et al. (2009) EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells. Mol. Nutr. Food Res., 53, 1156-1165.
25. Tan, M.J. et al. (2008) Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem. Biol.,15, 263-273.
26. Agarwal, C. et al. (2002) Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome crelease. Carcinogenesis, 23, 1869-1876.
27. Singh, R.P. et al. (2006) Effect of silibinin on the growth and progression ofprimary lung tumors in mice. J. Natl. Cancer Inst., 98, 846-855.
28. Singh, R.P. et al. (2007) Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft. Carcinogenesis, 28, 2567-2574.
29. Gu, M. et al. (2007) Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res., 67,3483-3491.
30. Ma, Y. et al. (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat. Rev. Cancer, 4, 966-977.
31. Oyadomari, S. et al. (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ., 11, 381-389.
32. Wada, T. et al. (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene, 23, 2838-2849.
33. Zarubin, T. et al. (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res., 15, 11-18.
34. Kaur, M. et al. (2011) Grape seed extract upregulates p21 (Cip1) through redox-mediated activation of ERK1/2 and posttranscriptional regulation leading to cell cycle arrest in colon carcinoma HT29 cells. Mol. Carcinog.,50, 553-562.
35. Koorstra, J.B. et al. (2008) Pancreatic carcinogenesis. Pancreatology, 8,110-125.
36. Olson, S.H. (2012) Selected medical conditions and risk of pancreatic cancer. Mol. Carcinog., 51, 75-97.
37. Kayahara, M. et al. (2010) Surgical implication of micrometastasis for pancreatic cancer. Pancreas, 39, 884-888.
38. Porzner, M. et al. (2011) Novel approaches to target pancreatic cancer. Curr. Cancer Drug Targets, 11, 698-713.
39. Nerurkar P.V. et al. (2010) Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes. BMC Complement. Altern. Med., 10, 34.
40. Singh, A. et al. (1998) Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papillomagenesis. Toxicol. Lett., 94, 37-46.
41. Konishi, T. et al. (2004) Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells. Br. J. Pharmacol., 143,379-387.
42. Limtrakul, P. et al. (2004) Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract. Cancer Chemother. Pharmacol., 54, 525-530.
43. Arlt, A. et al. (2010) Targeting apoptosis pathways in pancreatic cancer. Cancer Lett. [Epub ahead of print]
44. Pavlyukov, M.S. et al. (2011) Survivin monomer plays an essential role in apoptosis regulation. J. Biol. Chem., 286, 23296-23307.
45. Huang, Y. et al.(2004) Antagonizing XIAP-mediated caspase-3 inhibition. Achilles' heel of cancers? Cancer Cell, 5, 1-2.
46. Shrikhande, S.V. et al. (2006) Silencing of X-linked inhibitor of apoptosis(XIAP) decreases gemcitabine resistance of pancreatic cancer cells. Anticancer Res., 263265-3273.
47. Zhang, Z. et al. (2003) Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic. Biol. Med., 34,1333-1342.
48. Kavitha, N. et al. (2011) Influence of Momordica charantia on oxidative stress-induced perturbations in brain monoamines and plasma corticosterone in albino rats. Indian J. Pharmacol., 43, 424-428.
49. Ching, R.H. et al. (2011) Supplementation of bitter melon to rats fed a highfructosediet during gestation and lactation ameliorates fructose-induced dyslipidemia and hepatic oxidative stress in male offspring. J. Nutr., 141,1664-1672.
50. Nerurkar, P.V. et al. (2011) Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation. J. Neuroinflammation, 8, 64.
51. Thenmozhi, A.J. et al. (2010) Antioxidant potential of Momordica charantia in ammonium chloride-induced hyperammonemic rats. Evid. Based Complement. Alternat. Med. [Epub ahead of print]
52. Cheng, S. et al. (2010) Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin. Cancer Res., 16,5679-5691.
53. Shrotriya, S. et al. (2012) Generation of reactive oxygen species by grape seed extract causes irreparable DNA damage leading to G2/M arrest and apoptosis selectively in head and neck squamous cell carcinoma cells. Carcinogenesis, 33, 848-858.
54. Rigas, B. et al. (2008) Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. Br. J. Cancer, 98, 1157-1160.
55. Schumacker, P.T. (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell, 10, 175-176.
56. Carling, D. et al. (2011) AMP-activated protein kinase: nature's energy sensor. Nat. Chem. Biol., 7, 512-518.
57. Hardie, D.G. (2011) Sensing of energy and nutrients by AMP-activated protein kinase. Am. J. Clin. Nutr., 93, 891S-8916.
58. Chandra, D. et al. (2006) Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome. Cell, 125,1333-1346.